Property Summary

NCBI Gene PubMed Count 41
Grant Count 24
R01 Count 8
Funding $1,707,205.46
PubMed Score 28.46
PubTator Score 29.89

Knowledge Summary


No data available


Gene RIF (27)

26651479 Endogenous TMEM106B was partly sequestered in CHMP2B-positive structures. The roles of SNPs T185, S185, or S134N in endosomal sorting complexes required for transport were studied. T185 is a risk factor in neurodegeneration with endolysosomal defects.
25653292 Common variants in TMEM106B serve as a distinct risk factor for TDP-43 pathology in older persons without frontotemporal lobe dementia.
25470345 This study confirmed that specific TMEM106B single-nucleotide polymorphisms is associated with HS-Aging pathology in the Alzheimer disease.
25114081 TMEM106b variability does not influence Alzheimer disease risk or plasma progranulin levels.
25096617 Study suggests that TMEM106B is associated with frontotemporal dementia, although the extent of this effect is difficult to be estimated by using clinical frontotemporal dementia series
25085782 It is a risk factor for frontotemporal lobar degeneration.
25066864 Neuronal TMEM106B plays a central role in regulating lysosomal size, motility and responsiveness to stress, highlighting the possible role of lysosomal biology in FTLD-TDP.
24899141 The HpScl groups (Hippocampual Sclerosis and Hippocampual Sclerosis-AD) were more likely to exhibit genetic variants in TMEM106B that are associated with frontotemporal lobar degeneration.
24872421 Regulated intramembrane proteolysis of the frontotemporal lobar degeneration risk factor, TMEM106B, by signal peptide peptidase-like 2a (SPPL2a).
24731779 results show that, in nondemented persons, TMEM106B influences the volume of temporal brain regions that are important for language processing.

AA Sequence


Text Mined References (47)

PMID Year Title
26651479 2015 TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.
25653292 2015 The TMEM106B locus and TDP-43 pathology in older persons without FTLD.
25470345 2015 Reassessment of risk genotypes (GRN, TMEM106B, and ABCC9 variants) associated with hippocampal sclerosis of aging pathology.
25255805 2014 Global profiling of co- and post-translationally N-myristoylated proteomes in human cells.
25114081 2015 Transmembrane protein 106B gene (TMEM106B) variability and influence on progranulin plasma levels in patients with Alzheimer's disease.
25096617 2015 Association of TMEM106B rs1990622 marker and frontotemporal dementia: evidence for a recessive effect and meta-analysis.
25085782 2014 Defining the association of TMEM106B variants among frontotemporal lobar degeneration patients with GRN mutations and C9orf72 repeat expansions.
25066864 2014 Lysosome size, motility and stress response regulated by fronto-temporal dementia modifier TMEM106B.
24899141 2014 Differential clinicopathologic and genetic features of late-onset amnestic dementias.
24872421 2014 Regulated intramembrane proteolysis of the frontotemporal lobar degeneration risk factor, TMEM106B, by signal peptide peptidase-like 2a (SPPL2a).